Hydrafacial Investor Day Presentation Deck
Our three-year plan
At least triple adjusted EBITDA (vs. 2022)
18 - 20%
2023E
Adjusted EBITDA
margin
113
25 - 30%
2025E
Adjusted EBITDA
margin
Value engineering efforts creating gross
margin expansion
Shift mix towards consumables
→ Operating leverage across the expense base
Note: Adjusted EBITDA is a non-GAAP measure. See appendix for a definition and discussion. Our achievement of the anticipated results is subject to risks and uncertainties, including those disclosed in our filings
with the SEC. The plan does not take into account the impact of any unanticipated developments in the business or changes in the operating environment, nor does it take into account the impact of our
acquisitions, dispositions or financings during 2022. Our plan assumes a largely reopened global market, which would be negatively impacted if closures or other restrictive measures persist or are reimplemented.
BEAUTYHEALTH™View entire presentation